TY - JOUR
T1 - Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis
T2 - A first in Australia
AU - Azzam, Omar
AU - Crowe, Amy
AU - Sajiv, Cherian
AU - Pawar, Basant
PY - 2015
Y1 - 2015
N2 - A 33-year-old Caucasian man with end-stage renal disease secondary to biopsy-proven IgA nephropathy, managed with continuous ambulatory peritoneal dialysis (PD), presented with PD-related peritonitis, the causal organism being a non-branching Gram-positive bacillus, Rhodococcus equi. Initial empirical Gram positive and negative coverage with cefazolin and ceftazidime was unsuccessful, but following isolation of the organism, and conversion to intraperitoneal vancomycin and oral ciprofloxacin, the peritonitis episode resolved. At day 10, vancomycin was switched to azithromycin for a total of 6 weeks of antimicrobial therapy. The PD catheter was preserved, and the patient remained peritonitis-free at 6 months of follow-up.
AB - A 33-year-old Caucasian man with end-stage renal disease secondary to biopsy-proven IgA nephropathy, managed with continuous ambulatory peritoneal dialysis (PD), presented with PD-related peritonitis, the causal organism being a non-branching Gram-positive bacillus, Rhodococcus equi. Initial empirical Gram positive and negative coverage with cefazolin and ceftazidime was unsuccessful, but following isolation of the organism, and conversion to intraperitoneal vancomycin and oral ciprofloxacin, the peritonitis episode resolved. At day 10, vancomycin was switched to azithromycin for a total of 6 weeks of antimicrobial therapy. The PD catheter was preserved, and the patient remained peritonitis-free at 6 months of follow-up.
UR - http://www.scopus.com/inward/record.url?scp=84946078919&partnerID=8YFLogxK
U2 - 10.1136/bcr-2014-207753
DO - 10.1136/bcr-2014-207753
M3 - Article
C2 - 26438670
AN - SCOPUS:84946078919
SN - 1757-790X
VL - 2015
JO - BMJ Case Reports
JF - BMJ Case Reports
M1 - 207753
ER -